Literature DB >> 27452364

Idiopathic hypercalciuria and formation of calcium renal stones.

Fredric L Coe1, Elaine M Worcester1, Andrew P Evan2.   

Abstract

The most common presentation of nephrolithiasis is idiopathic calcium stones in patients without systemic disease. Most stones are primarily composed of calcium oxalate and form on a base of interstitial apatite deposits, known as Randall's plaque. By contrast some stones are composed largely of calcium phosphate, as either hydroxyapatite or brushite (calcium monohydrogen phosphate), and are usually accompanied by deposits of calcium phosphate in the Bellini ducts. These deposits result in local tissue damage and might serve as a site of mineral overgrowth. Stone formation is driven by supersaturation of urine with calcium oxalate and brushite. The level of supersaturation is related to fluid intake as well as to the levels of urinary citrate and calcium. Risk of stone formation is increased when urine citrate excretion is <400 mg per day, and treatment with potassium citrate has been used to prevent stones. Urine calcium levels >200 mg per day also increase stone risk and often result in negative calcium balance. Reduced renal calcium reabsorption has a role in idiopathic hypercalciuria. Low sodium diets and thiazide-type diuretics lower urine calcium levels and potentially reduce the risk of stone recurrence and bone disease.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27452364      PMCID: PMC5837277          DOI: 10.1038/nrneph.2016.101

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


  117 in total

1.  Apatite plaque particles in inner medulla of kidneys of calcium oxalate stone formers: osteopontin localization.

Authors:  Andrew P Evan; Fredric L Coe; Susan R Rittling; Sharon M Bledsoe; Youzhi Shao; James E Lingeman; Elaine M Worcester
Journal:  Kidney Int       Date:  2005-07       Impact factor: 10.612

2.  Evidence for increased postprandial distal nephron calcium delivery in hypercalciuric stone-forming patients.

Authors:  Elaine M Worcester; Fredric L Coe; Andrew P Evan; Kristin J Bergsland; Joan H Parks; Lynn R Willis; Daniel L Clark; Daniel L Gillen
Journal:  Am J Physiol Renal Physiol       Date:  2008-08-20

3.  Renal crystal deposits and histopathology in patients with cystine stones.

Authors:  A P Evan; F L Coe; J E Lingeman; Y Shao; B R Matlaga; S C Kim; S B Bledsoe; A J Sommer; M Grynpas; C L Phillips; E M Worcester
Journal:  Kidney Int       Date:  2006-05-17       Impact factor: 10.612

4.  Effect of dietary modification on urinary stone risk factors.

Authors:  Charles Y C Pak; Clarita V Odvina; Margaret S Pearle; Khashayar Sakhaee; Roy D Peterson; John R Poindexter; Linda J Brinkley
Journal:  Kidney Int       Date:  2005-11       Impact factor: 10.612

5.  Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones.

Authors:  Joan H Parks; Elaine M Worcester; Fredric L Coe; Andrew P Evan; James E Lingeman
Journal:  Kidney Int       Date:  2004-08       Impact factor: 10.612

6.  Intra-tubular deposits, urine and stone composition are divergent in patients with ileostomy.

Authors:  Andrew P Evan; James E Lingeman; Fredric L Coe; Sharon B Bledsoe; Andre J Sommer; James C Williams; Amy E Krambeck; Elaine M Worcester
Journal:  Kidney Int       Date:  2009-08-26       Impact factor: 10.612

7.  Effects of low-calcium diet on urine calcium excretion, parathyroid function and serum 1,25(OH)2D3 levels in patients with idiopathic hypercalciuria and in normal subjects.

Authors:  F L Coe; M J Favus; T Crockett; A L Strauss; J H Parks; A Porat; C L Gantt; L M Sherwood
Journal:  Am J Med       Date:  1982-01       Impact factor: 4.965

8.  Dietary hypercalciuria in patients with calcium oxalate kidney stones.

Authors:  W J Burtis; L Gay; K L Insogna; A Ellison; A E Broadus
Journal:  Am J Clin Nutr       Date:  1994-09       Impact factor: 7.045

9.  In idiopathic calcium oxalate stone-formers, unattached stones show evidence of having originated as attached stones on Randall's plaque.

Authors:  Nicole L Miller; James C Williams; Andrew P Evan; Sharon B Bledsoe; Fredric L Coe; Elaine M Worcester; Larry C Munch; Shelly E Handa; James E Lingeman
Journal:  BJU Int       Date:  2009-06-22       Impact factor: 5.588

10.  Phenotypic characterization of kidney stone formers by endoscopic and histological quantification of intrarenal calcification.

Authors:  Michael P Linnes; Amy E Krambeck; Lynn Cornell; James C Williams; Mark Korinek; Eric J Bergstralh; Xujian Li; Andrew D Rule; Cynthia M McCollough; Terri J Vrtiska; John C Lieske
Journal:  Kidney Int       Date:  2013-05-22       Impact factor: 10.612

View more
  55 in total

1.  Randall's plaque in stone formers originates in ascending thin limbs.

Authors:  Andrew P Evan; Fredric L Coe; James Lingeman; Sharon Bledsoe; Elaine M Worcester
Journal:  Am J Physiol Renal Physiol       Date:  2018-08-01

Review 2.  Renal phosphate handling and inherited disorders of phosphate reabsorption: an update.

Authors:  Carsten A Wagner; Isabel Rubio-Aliaga; Nati Hernando
Journal:  Pediatr Nephrol       Date:  2017-12-23       Impact factor: 3.714

3.  Chlorthalidone Is Superior to Potassium Citrate in Reducing Calcium Phosphate Stones and Increasing Bone Quality in Hypercalciuric Stone-Forming Rats.

Authors:  Nancy S Krieger; John R Asplin; Ignacio Granja; Felix M Ramos; Courtney Flotteron; Luojing Chen; Tong Tong Wu; Marc D Grynpas; David A Bushinsky
Journal:  J Am Soc Nephrol       Date:  2019-05-17       Impact factor: 10.121

4.  Microcalcifications in stone-obstructed human submandibular gland are associated with apoptosis and cell proliferation.

Authors:  Ivan Lau; Ajay Potluri; Cliff-Lawrence Ibeh; Robert S Redman; Edina Paal; Bidhan C Bandyopadhyay
Journal:  Arch Oral Biol       Date:  2017-06-07       Impact factor: 2.633

5.  Chlorthalidone vs. potassium citrate in a model of hypercalciuria: differential effects on stone and bone.

Authors:  Gianmarco Lombardi; Pietro Manuel Ferraro; Giovanni Gambaro
Journal:  Ann Transl Med       Date:  2019-09

Review 6.  Effectiveness of Treatment Modalities on Kidney Stone Recurrence.

Authors:  Anna L Zisman
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-22       Impact factor: 8.237

7.  miR-125a-5p: a novel regulator of SLC26A6 expression in intestinal epithelial cells.

Authors:  Arivarasu N Anbazhagan; Shubha Priyamvada; Alip Borthakur; Seema Saksena; Ravinder K Gill; Waddah A Alrefai; Pradeep K Dudeja
Journal:  Am J Physiol Cell Physiol       Date:  2019-05-01       Impact factor: 4.249

Review 8.  Genetics of common complex kidney stone disease: insights from genome-wide association studies.

Authors:  Runolfur Palsson; Olafur S Indridason; Vidar O Edvardsson; Asmundur Oddsson
Journal:  Urolithiasis       Date:  2018-12-06       Impact factor: 3.436

Review 9.  Uromodulin: from physiology to rare and complex kidney disorders.

Authors:  Olivier Devuyst; Eric Olinger; Luca Rampoldi
Journal:  Nat Rev Nephrol       Date:  2017-08-07       Impact factor: 28.314

10.  Educational review: role of the pediatric nephrologists in the work-up and management of kidney stones.

Authors:  Carmen Inés Rodriguez Cuellar; Peter Zhan Tao Wang; Michael Freundlich; Guido Filler
Journal:  Pediatr Nephrol       Date:  2019-01-04       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.